Site-directed mutagenesis for the production of mutant TP53 gene and analysis of its tumor suppressor activity
The p53 therapy based approach is a good candidate for treatment of TP53-defect cancer. However, this treatment is unsuitable for some cancer cases especially for that caused by dominant-negative activity of the mutant p53 protein. Thus, more effective treatment is needed to overcome this problem an...
Main Authors: | Bakhtiar, M. Taher, Solachuddin Jauhari , Arief Ichwan |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2012
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/22804/ http://irep.iium.edu.my/22804/ http://irep.iium.edu.my/22804/1/zafirah_ICBS_abstract.pdf |
Similar Items
-
Production of recombinant p53 protein by PCR-based site directed mutagenesis of plasmid DNA
by: Bakhtiar, M. Taher, et al.
Published: (2010) -
Gene therapy in oral cancer: a promising prospect
by: Arief Ichwan, Solachuddin Jauhari
Published: (2016) -
Is a TNF alpha polymorphism responsible for mutations in the TP53 gene?
by: Berglund, Mattias, et al.
Published: (2011) -
Construction of Streptococcus pyogenes mutants by allele replacement mutagenesis
by: Shahdan, Intan Azura, et al.
Published: (2010) -
Silencing endogenous mutant P53 Using Sirna Induces
P73-Mediated Apoptosis in Human Head And Neck Squamous Cell
Carcinoma
by: Arief Ichwan, Solachuddin Jauhari, et al.
Published: (2011)